What's New in the U.S. HIV Clinical Guidelines
We walk you through the most recent updates to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV.
Featured
Researchers Recommend Screening All People With HIV for Elevated Liver Function Values
Authors of a literature review note the high prevalence of liver disease among people with HIV and recommend a step-by-step approach to management.
Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors
This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.
Researchers Crave More Data on HIV Care Continuum Programs for Recently Incarcerated People
Sixteen years after the success of Project START for HIV risk reduction, we still don't know what works best for helping people with HIV stay in care after prison.
Native Americans Have HIV Treatment Adherence Rates on Par With Other Groups
Despite rising HIV rates and structural barriers to accessing care, American Indians and Alaska Natives do not have worse clinical outcomes when they're in care.
De-Simplifying Single-Tablet Regimens for HIV Treatment
A Canadian study of this cost-saving approach found high acceptance of de-simplification among people already on a single-tablet regimen, and even higher rates among people who were just initiating single-tablet treatment.
Why Nurses Should Take the HIV Self-Test
People newly diagnosed with HIV must be able to access treatment and support, which could be improved if guided by people who have been taken the test themselves, researchers found.
PositiveLinks: Mobile Intervention for People With HIV
Study results of an intervention that includes a custom smartphone app tailored to the needs and preferences of a rural population of people with HIV living in the southern U.S.
Doravirine Sets a New Standard for NNRTIs -- but What Role in HIV Treatment Today?
"Since this appears to be a 'best in class' drug, doravirine has enough advantages that it is a useful advance in HIV therapy, if not a transformational one," writes Paul Sax, M.D.
FDA Approves Doravirine (Pifeltro) and New FDC With TDF/3TC (Delstrigo) in the U.S.
On Aug. 30, 2018, the U.S. FDA approved doravirine as a separate formulation for use with ART and in a fixed-dose combination with generic tenofovir DF and lamivudine (3TC).
More People With HIV Virally Suppressed on Doravirine Than Darunavir at 96 Weeks, Study Shows
After 96 weeks, more people achieved viral suppression on a doravirine-based antiretroviral drug regimen compared with a darunavir (Prezista)-based one, according to data presented at the recent 22nd International AIDS Conference.